Company

PRD Therapeutics, Inc.

PRD Therapeutics develops drugs for rare disorders involving abnormal lipid metabolism.

About

PRD Therapeutics researches lipid metabolism regulators, including PRD001, an oral lipid-lowering drug for HoFH. Founded in 2021, the company is based in Tokyo, Japan. It raised JPY 1.3 billion in Series A funding in September 2023 to conduct clinical trials for PRD001.

1Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in